AR079680A1 - Composiciones y metodos para el cuidado bucal - Google Patents

Composiciones y metodos para el cuidado bucal

Info

Publication number
AR079680A1
AR079680A1 ARP100104852A ARP100104852A AR079680A1 AR 079680 A1 AR079680 A1 AR 079680A1 AR P100104852 A ARP100104852 A AR P100104852A AR P100104852 A ARP100104852 A AR P100104852A AR 079680 A1 AR079680 A1 AR 079680A1
Authority
AR
Argentina
Prior art keywords
loss
mmp
isopropyl
combinations
well
Prior art date
Application number
ARP100104852A
Other languages
English (en)
Inventor
Wei Wang
Virginia Barnes
Harsh Trivedi
Tao Xu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR079680A1 publication Critical patent/AR079680A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/38—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicacion 1: Un método para el tratamiento de un estado de salud asociado con la expresion aberrante de la MMP-13, caracterizado porque comprende administrar a un paciente una cantidad efectiva desde el punto de vista terapéutico de NDM de extracto de arándano rojo, ácido acetil ceto beta-boswélico, resveratrol, 2-isopropil-5-metilciclohexil 2-hidroxifenilcarbamato, 4-acetamidofenil 2-isopropil-5-metilciclohexil carbonato, así como combinaciones de dos o más de los mismos. Reivindicacion 2: El método de acuerdo con la Reivindicacion 1, caracterizado porque el estado de salud asociado con la expresion aberrante de la MMP-13 se selecciona del grupo que consiste de degradacion de la matriz extracelular, pérdida de acoplamiento de uno o más dientes, pérdida dental, movilidad dental, formacion de surcos, pérdida osea, así como combinaciones de dos o más de los mismos. Reivindicacion 10: La composicion de acuerdo con cualquiera de las Reivindicaciones 4 a 9, caracterizada porque la composicion es un dentífrico.
ARP100104852A 2009-12-21 2010-12-21 Composiciones y metodos para el cuidado bucal AR079680A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28835909P 2009-12-21 2009-12-21

Publications (1)

Publication Number Publication Date
AR079680A1 true AR079680A1 (es) 2012-02-15

Family

ID=43827777

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104852A AR079680A1 (es) 2009-12-21 2010-12-21 Composiciones y metodos para el cuidado bucal

Country Status (15)

Country Link
US (2) US8883179B2 (es)
EP (1) EP2515895B1 (es)
JP (1) JP5718360B2 (es)
CN (1) CN102781439B (es)
AR (1) AR079680A1 (es)
AU (1) AU2010339713B2 (es)
BR (1) BR112012015401A2 (es)
CA (1) CA2780821C (es)
CO (1) CO6481010A2 (es)
MX (1) MX2012006018A (es)
MY (1) MY154024A (es)
RU (1) RU2553500C2 (es)
TW (1) TW201141536A (es)
WO (1) WO2011084781A2 (es)
ZA (1) ZA201204530B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106420439A (zh) * 2016-08-28 2017-02-22 冯涵丽 除菌牙膏
CN108653174A (zh) * 2018-07-11 2018-10-16 杭州纳美智康科技有限公司 一种含银耳多糖的牙膏及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0939629A4 (en) * 1996-07-22 2002-07-17 Monsanto Co THIOL-SULFONAMIDES AS METALLOPROTEINAS INHIBITORS
CN1228780A (zh) 1996-08-28 1999-09-15 普罗克特和甘保尔公司 用作基质金属蛋白酶抑制剂的次膦酸酰胺
WO1998015525A1 (fr) * 1996-10-07 1998-04-16 Sumitomo Pharmaceuticals Co., Ltd. Acides hydroxamiques
US5840322A (en) * 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
EP1003720B1 (en) 1997-08-08 2004-03-31 Pfizer Products Inc. Aryloxyarylsulfonylamino hydroxamic acid derivatives
JPH11139947A (ja) 1997-11-11 1999-05-25 Sunstar Inc マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
FR2778337B1 (fr) 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
US6716883B1 (en) * 1998-12-24 2004-04-06 1333366 Ontario Inc. Composition useful to treat periodontal disease
GB9916562D0 (en) * 1999-07-14 1999-09-15 Pharmacia & Upjohn Spa 3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora
CA2312505A1 (en) 2000-06-27 2001-12-27 1333366 Ontario Inc. Resveratrol compositions for topical use in the treatment of oral diseases and infections
EP1663126A1 (de) 2003-09-09 2006-06-07 DSM IP Assets B.V. Oral wirkendes im wesentlichen wasserfreies topisches mittel enthaltend ein oder mehrere oxidationsempfindliche stoffe
CA2615444A1 (en) * 2005-07-15 2007-01-25 Donald J. Baker Compositions and methods for treating and preventing inflammatory and/or degenerative processes in humans and other animals
DE202006008905U1 (de) 2006-06-02 2006-08-17 Fritz, Uwe Zusatzstoff für Lebensmittel
AU2008229110A1 (en) 2007-03-19 2008-09-25 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
WO2008120220A1 (en) * 2007-04-03 2008-10-09 Ganga Raju Gokaraju Synergistic anti-inflammatory and antioxidant dietary supplement compositions
JP2010540647A (ja) * 2007-10-01 2010-12-24 コルゲート・パーモリブ・カンパニー 植物性抽出物を含有する口腔組成物
WO2009144179A1 (en) * 2008-05-30 2009-12-03 Symrise Gmbh & Co. Kg L-menthyl-n-(2-hydroxyphenyl)carbamate
MY170956A (en) * 2009-04-01 2019-09-20 Colgate Palmolive Co Menthol-derivative compounds and use thereof as oral and systemic active agents

Also Published As

Publication number Publication date
WO2011084781A3 (en) 2011-11-10
BR112012015401A2 (pt) 2017-03-14
TW201141536A (en) 2011-12-01
EP2515895A2 (en) 2012-10-31
RU2012130956A (ru) 2014-01-27
CN102781439A (zh) 2012-11-14
MX2012006018A (es) 2012-06-19
JP5718360B2 (ja) 2015-05-13
CA2780821C (en) 2014-08-26
RU2553500C2 (ru) 2015-06-20
CO6481010A2 (es) 2012-07-16
CN102781439B (zh) 2015-11-25
US9320696B2 (en) 2016-04-26
EP2515895B1 (en) 2018-02-14
JP2013515075A (ja) 2013-05-02
US20120294915A1 (en) 2012-11-22
CA2780821A1 (en) 2011-07-14
US8883179B2 (en) 2014-11-11
AU2010339713B2 (en) 2013-11-07
US20150086490A1 (en) 2015-03-26
AU2010339713A1 (en) 2012-06-07
ZA201204530B (en) 2014-11-26
MY154024A (en) 2015-04-30
WO2011084781A2 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
BR112012013473A2 (pt) composição para higiene oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral
HK1123484A1 (en) Method of using oxidative reductive potential water solution in dental applications
EA201290171A1 (ru) Вводимые перорально кортикостероидные композиции
CO6571900A2 (es) Composiciones famaceúticas del compuesto espiro-oxindol para adminsitración tópica y sus usos como agentes terapeúticos
TR201818927T4 (tr) Kataterlerde İyileştirme
AR062522A1 (es) Tratamiento de desordenes en cartilagos
UA104320C2 (ru) Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
BRPI0819690B8 (pt) uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas
DOP2011000047A (es) Agentes terapeuticos 414
CO6460709A2 (es) Composiciones borínicas
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
BRPI0924734A2 (pt) composição oral, e, métodos para preparar a composição oral, para alvejar um ingrediente ativo, para depositar um material bacteriostático ou bactericida sobre superfícies orais, para retardar ou previnir cárie dentária, método para ocluir túbulos dentinais, para tratar uma lesão por cárie, para calcificar uma polpa de dente exposta, e para calcificar a base de ou a totalidade de um buraco ou de uma fissura em um dente.
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
BR112012015750A2 (pt) composição para higiene oral, método para melhorar o cumprimento de um plano de tratamento pelo paciente com uma composição para higiene oral, e, método para branqueamento de uma superfície dental
IN2014DN10291A (es)
BR112015019802A2 (pt) formulações farmacêuticas de nitrito e usos das mesmas
CL2012001671A1 (es) Compuestos derivados de (metilsulfonil)-etil-bencenoisoindolina; composicion farmaceutica que los comprende, uso en el tratamiento del cancer, dolor, trastornos del snc, enfermedades dermatologicas, entre otras.
BR122021012549B8 (pt) Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva
AR079680A1 (es) Composiciones y metodos para el cuidado bucal
MD3905G2 (ro) Remediu medicamentos cu acţiune prelungită sub formă de gel pentru tratamentul afecţiunilor parodonţiului (variante)
EA201990419A1 (ru) Слаборастворимый комплекс или его сольват, фармацевтическая композиция и их применение
AR088845A1 (es) Composiciones farmaceuticas que contienen 7-(1h-imidazol-4-ilmetil)-5,6,7,8-tetrahidro-quinolina para el tratamiento de las enfermedades y las afecciones de la piel
NZ597675A (en) Medicament for the long term nsaid use
WO2014145636A3 (en) System and method for treatment of endodontic/periodontic conditions

Legal Events

Date Code Title Description
FB Suspension of granting procedure